Supplementary Data from Preclinical and Clinical Evidence that Deoxy-2-[&lt;sup&gt;18&lt;/sup&gt;F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer